What we know about remdesivir study and COVID-19 antibodies

Testing, both for active cases of COVID-19 and for antibodies indicating prior exposure to the disease, will be critical to resuming economic activity. In addition, scientists are racing to develop therapies for people who do get infected -- especially those who become seriously ill. Science correspondent Miles O’Brien joins Judy Woodruff to discuss the latest on COVID-19 testing and treatment.